COM:PROTAGONIST-INC
Protagonist Therapeutics Inc.
- Stock
Last Close
40.65
21/11 21:00
Market Cap
2.04B
Beta: -
Volume Today
936.37K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 20.06M - | 30.93M 54.14% | 231K 99.25% | 28.63M 12,293.07% | 27.36M 4.44% | 26.58M 2.84% | 60M 125.73% | ||||
cost of revenue | 3.31M - | ||||||||||
gross profit | 20.06M - | 30.93M 54.14% | 231K 99.25% | 28.63M 12,293.07% | 27.36M 4.44% | 26.58M 2.84% | 56.69M 113.27% | ||||
selling and marketing expenses | |||||||||||
general and administrative expenses | 1.86M - | 2.96M 59.30% | 6.96M 134.93% | 11.78M 69.21% | 13.70M 16.28% | 15.75M 14.98% | 18.64M 18.34% | 27.20M 45.92% | 31.74M 16.70% | 33.49M 5.52% | |
selling general and administrative expenses | 1.86M - | 2.96M 59.30% | 6.96M 134.93% | 11.78M 69.21% | 13.70M 16.28% | 15.75M 14.98% | 18.64M 18.34% | 27.20M 45.92% | 31.74M 16.70% | 33.49M 5.52% | |
research and development expenses | 7.46M - | 11.83M 58.61% | 25.70M 117.27% | 46.18M 79.66% | 59.50M 28.83% | 65.00M 9.25% | 74.51M 14.62% | 126.01M 69.12% | 126.22M 0.17% | 120.16M 4.80% | |
other expenses | -34K - | -1K - | -46K 4,500% | -149K 223.91% | -80K 46.31% | -201K 151.25% | |||||
cost and expenses | 9.32M - | 14.79M 58.75% | 32.67M 120.81% | 57.96M 77.43% | 73.19M 26.28% | 80.75M 10.33% | 93.14M 15.35% | 153.20M 64.48% | 157.95M 3.10% | 153.65M 2.72% | |
operating expenses | 9.32M - | 14.79M 58.75% | 32.67M 120.81% | 57.96M 77.43% | 73.19M 26.28% | 80.75M 10.33% | 93.14M 15.35% | 153.20M 64.48% | 157.95M 3.10% | 153.65M 2.72% | |
interest expense | 169K - | 598K 253.85% | -3.37M - | ||||||||
ebitda | -7.29M - | -14.46M 98.35% | -27.95M 93.22% | -37.90M 35.60% | -42.27M 11.54% | -77.71M 83.84% | -63.66M 18.08% | -125.55M 97.21% | -131.37M 4.64% | -90.34M 31.23% | |
operating income | -9.32M - | -14.79M 58.75% | -32.67M 120.81% | -37.90M 16.01% | -42.27M 11.54% | -80.52M 90.50% | -64.52M 19.88% | -125.84M 95.06% | -131.37M 4.39% | -93.65M 28.71% | |
depreciation and amortization | 258K - | 247K 4.26% | 317K 28.34% | 406K 28.08% | 527K 29.80% | 2.81M 433.59% | 854K 69.63% | 294K 65.57% | 3.37M 1,045.92% | 3.31M 1.69% | |
total other income expenses net | -1.77M - | -83K 95.31% | -4.75M 5,626.51% | 940K 119.78% | 2.55M 170.85% | 2.64M 3.81% | -329K 112.45% | 294K 189.36% | 3.98M 1,253.74% | -201K 105.05% | |
income before tax | -11.07M - | -14.86M 34.19% | -37.18M 150.22% | -36.96M 0.59% | -39.72M 7.48% | -77.88M 96.05% | -64.84M 16.74% | -125.55M 93.62% | -127.39M 1.47% | -78.95M 38.02% | |
income tax expense | 1.75M - | 64K 96.35% | 4.16M 6,400% | -406K 109.76% | -799K 96.80% | -691K 13.52% | 1.30M 288.86% | -2.92M 324.06% | -3.98M 36.11% | -14.90M 274.32% | |
net income | -11.07M - | -14.86M 34.19% | -37.18M 150.22% | -36.96M 0.59% | -38.92M 5.32% | -77.19M 98.30% | -66.15M 14.30% | -122.63M 85.38% | -123.41M 0.64% | -78.95M 36.02% | |
weighted average shs out | 5.88M - | 5.88M 0% | 6.50M 10.48% | 17.69M 172.15% | 22.36M 26.39% | 25.89M 15.78% | 34.40M 32.84% | 46.32M 34.67% | 49.04M 5.87% | 56.76M 15.74% | |
weighted average shs out dil | 5.88M - | 5.88M 0% | 6.50M 10.48% | 17.69M 172.15% | 22.36M 26.39% | 25.89M 15.78% | 34.40M 32.84% | 46.32M 34.67% | 49.04M 5.87% | 56.76M 15.74% | |
eps | -1.88 - | -2.52 34.04% | -5.72 126.98% | -2.09 63.46% | -1.74 16.75% | -2.98 71.26% | -1.92 35.57% | -2.65 38.02% | -2.52 4.91% | -1.39 44.84% | |
epsdiluted | -1.88 - | -2.52 34.04% | -5.72 126.98% | -2.09 63.46% | -1.74 16.75% | -2.98 71.26% | -1.92 35.57% | -2.65 38.02% | -2.52 4.91% | -1.39 44.84% |
All numbers in (except ratios and percentages)